Mesenchymal stem cells reduce inflammation, enhance bacterial clearance, and improve survival in sepsis.

This experiment hypothesized that mesenchymal stem cells (MSCs) would reduce sepsis-induced inflammation and improve survival in a polymicrobial model of sepsis. Their concluding data demonstrate that MSCs have beneficial effects on experimental sepsis, and suggest that immunomodulatory cell therapy may be an effective treatment to reduce sepsis-related morbidity and mortality.